Methods for manufacturing dosage forms

• US 7,122,143 B2
• Filed: 09/28/2001
• Issued: 10/17/2006
• Est. Priority Date: 09/28/2001
• Status: Expired due to Term

• Current Assignee: Johnson & Johnson Consumer Inc. (Johnson & Johnson)
• Original Assignee: McNeil-PPC Incorporated (Johnson & Johnson)
• Inventors: Plantz, Bernard F., Sowden, Harry S., Li, Shun Por
• Primary Examiner(s): ORTIZ, ANGELA Y
• Application Number:
  US09/966,497
• Publication Number:
  US 20030086973A1
• Time in Patent Office: 1,845 Days
• Field of Search: 264/250, 264/255, 264/259, 264/271.1, 264/299, 264/319, 264/328.1, 264/328.9, 264/328.14, 264/328.16, 264/328.8, 424/474, 424/476, 424/478, 424/489, 425/547, 425/566, 425/574, 425/576
• US Class Current: 264/271.1
• CPC Class Codes: A23G 3/04 Sugar-cookers
• CPC Class Codes: A23G 3/368 containing vitamins, antibiotics
• CPC Class Codes: A61J 3/005 Coating of tablets or the like coating of sweetmeats or confectionery A23G3/20; coating of granules in general B01J2/006
• CPC Class Codes: A61J 3/06 into the form of pills, lozenges or dragees
• CPC Class Codes: A61J 3/10 into the form of compressed tablets tablet presses B30B11/00
• CPC Class Codes: A61K 9/2853 obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, polyethylene oxide, poloxamers, poly(lactide-co-glycolide)
• CPC Class Codes: A61K 9/2873 Proteins, e.g. gelatin
• CPC Class Codes: A61K 9/2893 Tablet coating processes mechanical aspects A61J3/06
• CPC Class Codes: B30B 11/005 Control arrangements
• CPC Class Codes: B30B 15/0017 Deairing means

Abstract

Systems, methods and apparatuses for manufacturing dosage forms, and to dosage forms made using such systems, methods and apparatuses are provided. Novel compression, thermal cycle molding, and thermal setting molding modules are disclosed. One or more of such modules may be linked, preferably via novel transfer device, into an overall system for making dosage forms.

Claims

1. A method of making a dosage form containing a first medicant, which comprises

a) injecting through a nozzle that moves for injection and then retracts away from a mold cavity to close the mold cavity a flowable material containing said first medicant into said mold cavity, wherein the nozzle comprises valve body and tip, and after injection, the nozzle is retracted and the tip closes the mold cavity;

and

b) hardening by cooling within the mold cavity said flowable material into a solid molded dosage form having a shape substantially the same as the mold cavity, wherein substantially all of the flowable material injected into the mold cavity becomes part of the solid molded dosage form.

2. The method of claim 1, further comprising the step of heating said flowable material prior to injecting said flowable material into said mold cavity, and wherein said hardening step (b) comprises cooling said flowable material.

3. The method according to claim 2, wherein said mold cavity is heated prior to said injecting step (a) and cooled during said hardening step (b).

4. The method according to claim 3, wherein said mold cavity is heated and cooled using heat transfer fluids that circulate proximal to said mold cavity.

5. The method of claim 2, wherein said mold cavity is heated prior to said injection step (a) and cooled during said hardening step (b) using a single heat transfer fluid heated by a heat source and cooled by a heat sink.

6. The method according to claim 1, wherein said flowable material comprises a polymer.

7. The method according to claim 1, wherein said flowable material comprises a carbohydrate.

8. The method according to claim 1, wherein said flowable material comprises a fat.

9. The method according to claim 1, wherein said flowable material comprises a wax.

10. The method according to claim 1, wherein said flowable material comprises gelatin.

11. The method according to claim 10, further comprising heating said gelatin to a temperature above its gel point prior to said injecting step (a), and wherein said hardening step (b) comprises cooling said gelatin to a temperature below its gel point.

12. The method of claim 1, wherein said molded dosage form is substantially free of visible defects.

13. The method according to claim 1, further comprising the step of placing an insert in said mold cavity prior to said injecting step (a), such that said molded dosage form comprises an insert embedded therein.

14. The method according to claim 13, wherein said insert comprises a polymer.

15. The method according to claim 13, wherein said insert comprises a carbohydrate.

16. The method according to claim 13, wherein said insert comprises a fat.

17. The method according to claim 13, wherein said insert comprises a wax.

18. The method according to claim 13, wherein said insert comprises a second medicant.

19. The method according to claim 1 performed while said mold cavity is traveling along a circular path.

22. The method of claim 1 or 13, wherein the flowable material is substantially solvent-free.

20. A method of making a molded dosage form which comprises

a) heating a flowable material containing a pharmaceutical active ingredient;

b) injecting said flowable material through a nozzle that moves for injection and then retracts away from a mold cavity to close the mold cavity wherein the nozzle comprises a valve body tip, and after injection, the nozzle is retracted and the tip closes the mold cavity having an orifice into said mold cavity; and

c) hardening said flowable material into a solid molded dosage form having a shape substantially the same as the mold cavity;

wherein said hardening step (c) comprises cooling said flowable material and wherein said mold cavity is heated prior to said injecting step (b) and cooled during said hardening step (c), wherein substantially all of the flowable material injected into the mold cavity becomes part of the solid molded dosage form.

21. The method of claim 20, wherein a medicant is introduced into the mold cavity prior to said hardening step (c).